<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04292587</url>
  </required_header>
  <id_info>
    <org_study_id>08122018</org_study_id>
    <nct_id>NCT04292587</nct_id>
  </id_info>
  <brief_title>Prevalence of Hirsutism in Turkey: Data of The Dermatoendocrinology Study Group</brief_title>
  <official_title>Prevalence of Hirsutism in Turkey: Data of The Dermatoendocrinology Study Group</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istanbul Medeniyet University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istanbul Medeniyet University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hirsutism is defined as the excessive presence of terminal hairs in the androgen-sensitive
      areas of the female body, and it is one of the frequent reasons for presenting to dermatology
      outpatient clinics. Hirsutism influences 5% to 10% of women around the world and leads to
      psychological problems depending on ethnic and socio-cultural factors. It also causes
      material burden including medicines, cosmetic products and epilation procedures.

      The differences in the real prevalence of hirsutism in the Turkish population and the
      hirsutism prevalence and severity between the geographical regions of Turkey are not known.
      In this study, we aimed to determine the prevalence of hirsutism in women at the reproductive
      age within Turkey. The geographical regions of Turkey comprise seven regions and and all
      regions were included in this study. By considering the regions where ethnic differences were
      high including the east-west-south and north of our country, we aimed to find an answer to
      the question of whether there were differences in terms of the prevalence and severity of
      hirsutism among these regions. A comprehensive study aiming to determine the prevalence of
      hirsutism in Turkey has not been conducted.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Twenty-two provinces of Turkey's seven regions and 26 hospitals from these provinces will be
      included in the study. The number of samples was specified by the public health specialist on
      the 2018 census figures. The Turkish population consists of 80,810,525 people according to
      the data announced by the Turkish Statistical Institute in 2018. In order to determine the
      prevalence in Turkey, the sample size was calculated with a confidence interval of 99% and
      error margin of 1%, and the total number of individuals to be screened was designated as
      5861. The number of patients to be screened via the clustering method weighted by regions was
      specified as 1800 for the Marmara Region, 750 for the Aegean Region, 744 for the
      Mediterranean Region, 568 for the Black Sea Region, 932 for the Central Anatolia Region, 434
      for the Eastern Anatolia Region and 633 for the Southeastern Anatolia Region. The provinces
      that were thought to represent each region were selected via the cluster sampling method.

      During the study period, female patients aged between 18 and 45, who present to dermatology
      outpatient clinics, will be examined clinically until the number of patients designated for
      each study center is reached, and the hirsutism level of the patients diagnosed with
      hirsutism will be determined by using the modified Ferriman-Gallwey (mFG) scoring system. In
      this system, hair growth in nine regions (upper lip, chin, chest, upper back, lower back,
      upper abdomen, lower abdomen, upper arms and thighs) is graded between 0 and 4. And nine
      regions are scored between 0 (no terminal hairs) and 4 (excessive presence of terminal
      hairs). The score above 8 is considered hirsutism. The hirsutism family history, body mass
      index, menstrual cycle pattern, concomitant disease status (diabetes, hyperlipidemia,
      hypertension, thyroid disease), history of medication causing body hair growth, the acne
      presence and severity, presence and severity of androgenic alopecia, presence of seborrhea,
      presence and localization of acanthosis nigricans, presence of acrochordon, presence of
      hidradenitis suppurativa, presence of galactorrhea, presence of virilization symptoms and
      presence of cushingoid symptoms of all the examined patients will be investigated and
      recorded.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 3, 2020</start_date>
  <completion_date type="Anticipated">September 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Modified Ferriman-Gallwey Scoring System for Severity of Hirsutism</measure>
    <time_frame>1 day (At the time of the examination)</time_frame>
    <description>In this system, hair growth in nine regions (upper lip, chin, chest, upper back, lower back, upper abdomen, lower abdomen, upper arms and thighs) is graded between 0 and 4. And nine regions are scored between 0 (no terminal hairs) and 4 (excessive presence of terminal hairs). The score above 8 is considered hirsutism.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Concomitant disease status and the risk factors</measure>
    <time_frame>1 day (At the time of the examination)</time_frame>
    <description>Concomitant disease status (diabetes, hyperlipidemia, hypertension, thyroid disease), hirsutism family history, history of medication causing body hair growth, presence of seborrhea, presence and localization of acanthosis nigricans, presence of acrochordon, presence of hidradenitis suppurativa, presence of galactorrhea, presence of virilization symptoms and presence of cushingoid symptoms of all the examined patients will be determined and recorded.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body mass indices of the participants</measure>
    <time_frame>1 day (At the time of the examination)</time_frame>
    <description>BMI in kg/m^2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The presence and severity of acne in the participants</measure>
    <time_frame>1 day (At the time of the examination)</time_frame>
    <description>If acne is present, it will be classified as mild, moderate and severe.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The presence and severity of androgenic alopecia in the participants</measure>
    <time_frame>1 day (At the time of the examination)</time_frame>
    <description>If androgenic alopecia is present, it will be classified as Ludwig 1, Ludwig 2, Ludwig 3.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Menstrual cycle pattern of the participants</measure>
    <time_frame>1 day (At the time of the examination)</time_frame>
    <description>The menstrual cycle pattern of the participants will be classified as regular, oligomenorrhea, amenorrhea, polimenorrhea</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">5861</enrollment>
  <condition>Hirsutism</condition>
  <arm_group>
    <arm_group_label>Women with hirsutism</arm_group_label>
    <description>Women between the ages of 18-45 with hirsutism</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Women without hirsutism</arm_group_label>
    <description>Women between the ages of 18-45 without hirsutism</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        During the study period, female patients aged between 18 and 45, who present to dermatology
        outpatient clinics, will be examined consecutive until the number of patients designated
        for each study center is reached.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female patients aged between 18 and 45, who presented to the dermatology outpatient
             clinics for any reason

          -  Not being in pregnancy and lactation period

          -  Not applying permanent epilation

          -  Not using temporary hair reduction methods in the last 4 weeks

          -  Not using oral contraceptive, corticosteroid, cyclosporin or spironolactone in the
             last 3 months

        Exclusion Criteria:

          -  Female patients below the age of 18, above 45 and men in any age group

          -  Pregnant women and women in lactation period

          -  Patients who had permanent epilation

          -  Patients who had temporary hair reduction methods in the last 4 weeks

          -  Patients taking oral contraceptive, corticosteroid, cyclosporin or spironolactone in
             the last 3 months
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Filiz Cebeci Kahraman, Assoc. Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Health Sciences, Goztepe Training and Research Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Filiz Cebeci Kahraman, Assoc. Prof.</last_name>
    <phone>+90 537 372 47 22</phone>
    <email>cebecifiliz@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sevil Savas Erdogan, M.D.</last_name>
    <phone>+90 554 261 68 54</phone>
    <email>doktorsevilsavas@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Adana City Training and Research Hospital</name>
      <address>
        <city>Adana</city>
        <zip>01358</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tugba Yülek, M.D.</last_name>
      <email>tuubakarakas@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>School of Medicine, Aksaray University</name>
      <address>
        <city>Aksaray</city>
        <zip>68000</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emel Erdal Çalıkoglu, Prof.</last_name>
      <email>emelerdal@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>School of Medicine, Ankara Yıldırım Beyazıt University</name>
      <address>
        <city>Ankara</city>
        <zip>06010</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Selma Emre, Prof.</last_name>
      <email>dr_semre@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>School of Medicine, Aydın Adnan Menderes University</name>
      <address>
        <city>Aydın</city>
        <zip>09100</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Münevver Güven, Asst. Prof.</last_name>
      <email>munevver.guven@adu.edu.tr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bitlis Tatvan State Hospital</name>
      <address>
        <city>Bitlis</city>
        <zip>13200</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mustafa Kaan Tasolar, M.D.</last_name>
      <email>kaan_tasolar@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>School of Medicine, Uludag University</name>
      <address>
        <city>Bursa</city>
        <zip>16285</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kenan Aydogan, Prof.</last_name>
      <email>aydogank@uludag.edu.tr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Health Sciences, Gazi Yasargil Training and Research Hospital</name>
      <address>
        <city>Diyarbakır</city>
        <zip>21070</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Semahat Alp Erdal, M.D.</last_name>
      <email>semahatalperdal@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>School of Medicine, Trakya University</name>
      <address>
        <city>Edirne</city>
        <zip>22030</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sezgi Sarıkaya Solak, Asst. Prof.</last_name>
      <email>sezgisarikaya@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>School of Medicine, Eskisehir Osmangazi University</name>
      <address>
        <city>Eskisehir</city>
        <zip>26040</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hilal Kaya Erdogan, Assoc. Prof.</last_name>
      <email>hilalkayaerdogan@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>School of Medicine, Gaziantep University</name>
      <address>
        <city>Gaziantep</city>
        <zip>27310</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Orhan Ozgöztası, Prof.</last_name>
      <email>ozgoztasi@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>School of Medicine, Süleyman Demirel University</name>
      <address>
        <city>Isparta</city>
        <zip>32260</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Havva Hilal Ayvaz Çelik, Asst. Prof.</last_name>
      <email>drhhilalayvaz@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Health Sciences, Bakırköy Sadi Konuk Training and Research Hospital</name>
      <address>
        <city>Istanbul</city>
        <zip>34147</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Burce Can Kuru, Assoc. Prof.</last_name>
      <email>drburcecan@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Health Sciences, Sultan 2. Abdulhamid Han Training and Research Hospital</name>
      <address>
        <city>Istanbul</city>
        <zip>34668</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sevil Savas Erdogan, M.D.</last_name>
      <phone>+90 554 261 68 54</phone>
      <email>doktorsevilsavas@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Istanbul Medeniyet University, Goztepe Research and Training Hospital</name>
      <address>
        <city>Istanbul</city>
        <zip>34730</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Filiz Cebeci Kahraman, Assoc. Prof.</last_name>
      <phone>+90 537 372 47 22</phone>
      <email>cebecifiliz@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Health Sciences, Umraniye Training and Research Hospital</name>
      <address>
        <city>Istanbul</city>
        <zip>34764</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>İlkin Zindancı, Assoc. Prof.</last_name>
      <email>ilkin.dr@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Marmara University Pendik Training and Research Hospital</name>
      <address>
        <city>Istanbul</city>
        <zip>34899</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andac Salman, Asst. Prof.</last_name>
      <email>asalmanitf@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>School of Medicine,Izmir Katip Celebi University</name>
      <address>
        <city>Izmir</city>
        <zip>35620</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ali Karakuzu, Prof.</last_name>
      <email>dr.karakuzu@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>School of Medicine,Kahramanmaras Sutcu Imam University</name>
      <address>
        <city>Kahramanmaras</city>
        <zip>46050</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Perihan Oztürk, Assoc. Prof.</last_name>
      <email>drperihanozturk@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>School of Medicine, Kocaeli University</name>
      <address>
        <city>Kocaeli</city>
        <zip>41001</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dilek Bayramgürler, Prof.</last_name>
      <email>dbayramgurler@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Meram School of Medicine, Necmettin Erbakan University</name>
      <address>
        <city>Konya</city>
        <zip>42090</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arzu Ataseven, Assoc. Prof.</last_name>
      <email>arzuataseven@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>School of Medicine, Celal Bayar University</name>
      <address>
        <city>Manisa</city>
        <zip>45140</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gülsüm Gencoglan, Prof.</last_name>
      <email>ggencoglan@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sanlıurfa Training and Research Hospital</name>
      <address>
        <city>Sanlıurfa</city>
        <zip>63300</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isa An, M.D.</last_name>
      <email>is_an89@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>School of Medicine, Namık Kemal University</name>
      <address>
        <city>Tekirdag</city>
        <zip>59030</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hülya Albayrak, Asst. Prof.</last_name>
      <email>drhulyaalbayrak@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>School of Medicine,Tokat Gaziosmanpasa University</name>
      <address>
        <city>Tokat</city>
        <zip>60030</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zennure Takcı, Assoc. Prof.</last_name>
      <email>drzennure80@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>School of Medicine,Karadeniz Technical University</name>
      <address>
        <city>Trabzon</city>
        <zip>61080</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leyla Baykal Selcuk, Asst. Prof.</last_name>
      <email>lb_leyla@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Health Sciences, Van Training and Research Hospital</name>
      <address>
        <city>Van</city>
        <zip>65100</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Murat Oztürk, M.D.</last_name>
      <email>chayacholic@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Li R, Qiao J, Yang D, Li S, Lu S, Wu X, Wei Z. Epidemiology of hirsutism among women of reproductive age in the community: a simplified scoring system. Eur J Obstet Gynecol Reprod Biol. 2012 Aug;163(2):165-9. doi: 10.1016/j.ejogrb.2012.03.023. Epub 2012 Jun 28.</citation>
    <PMID>22748844</PMID>
  </reference>
  <reference>
    <citation>Lumezi BG, Berisha VL, Pupovci HL, Goçi A, Hajrushi AB. Grading of hirsutism based on the Ferriman-Gallwey scoring system in Kosovar women. Postepy Dermatol Alergol. 2018 Dec;35(6):631-635. doi: 10.5114/ada.2018.77615. Epub 2018 Nov 13.</citation>
    <PMID>30618534</PMID>
  </reference>
  <reference>
    <citation>Fatemi Naeini F, Najafian J, Jazebi N. Hirsutism and body mass index in a representative sample of Iranian people. ARYA Atheroscler. 2012 Spring;8(1):43-54.</citation>
    <PMID>23056100</PMID>
  </reference>
  <reference>
    <citation>Carmina E. Prevalence of idiopathic hirsutism. Eur J Endocrinol. 1998 Oct;139(4):421-3.</citation>
    <PMID>9820619</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>February 26, 2020</study_first_submitted>
  <study_first_submitted_qc>March 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 3, 2020</study_first_posted>
  <last_update_submitted>March 1, 2020</last_update_submitted>
  <last_update_submitted_qc>March 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istanbul Medeniyet University</investigator_affiliation>
    <investigator_full_name>Filiz Cebeci Kahraman</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Ferriman-Gallwey score, hirsutism, prevalence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hirsutism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

